PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1756491
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1756491
RSV Diagnostics Market, By Product, By Method, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
RSV Diagnostics Market size was valued at USD 6,456.67 Billion in 2024, expanding at a CAGR of 5.87% from 2024 to 2032.
Respiratory Syncytial Virus (RSV) diagnostics involve detecting the presence of RSV infection in patients, primarily through respiratory samples like nasal swabs. The main diagnostic methods include nucleic acid amplification tests (NAATs) such as real-time PCR, which are highly sensitive and specific, rapid antigen detection tests (RADTs) that provide quicker but sometimes less accurate results, and viral culture, which is slower and less commonly used. Accurate detection is crucial for timely treatment and infection control, especially in infants and elderly patients vulnerable to severe RSV disease. Testing is usually performed within the early days of symptom onset to ensure reliability.
RSV Diagnostics Market- Market Dynamics
Increasing Prevalence of Respiratory Infections
The rising incidence of respiratory infections, particularly among infants, elderly individuals, and immunocompromised patients, is a major driver for the RSV diagnostics market. Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, resulting in significant hospitalizations and healthcare costs. Early and accurate diagnosis through advanced RSV diagnostic tools helps in timely treatment and reduces the spread of infection. Additionally, growing awareness among healthcare providers and improved access to diagnostic technologies further fuel market growth. These factors collectively boost demand for efficient and rapid RSV diagnostic solutions globally.
RSV Diagnostics Market- Key Insights
According to our research analyst, the global RSV Diagnostics Market is expected to develop at a CAGR of approximately 5.87% between 2024-2032.
Segmented by Product in 2024, the Kits and Assays category dominated the market.
Based on End User, the Hospitals and Clinics segment generated the most income in 2024.
On the basis of region, in 2024, North America was the region with the highest revenue.
RSV Diagnostics Market- Segmentation Analysis:
The global RSV Diagnostics Market is divided into Four categories: Product, Method, End User and Region.
By product, the RSV diagnostics market is segmented into Kits and Assays, Instruments, and Other Products. Kits and Assays include reagents and test kits used for detecting RSV antigens or nucleic acids in patient samples. Instruments refer to the devices and analyzers used to perform diagnostic tests, such as PCR machines and immunoassay readers. Other Products encompass consumables and accessories required during testing. Among these segments, Kits and Assays hold the dominant share due to their critical role in providing rapid and accurate results, which are essential for timely clinical decision-making. The convenience, ease of use, and advancements in assay technologies have driven strong adoption of kits across hospitals, clinics, and diagnostic laboratories, making this segment the largest revenue contributor in the RSV diagnostics market.
By end user, the RSV diagnostics market is segmented into Hospitals and Clinics, Clinical Laboratories, and Home Care. Hospitals and Clinics represent healthcare facilities where patients receive diagnosis and treatment directly, often handling a high volume of respiratory cases. Clinical Laboratories specialize in conducting diagnostic tests with advanced equipment and skilled personnel, serving multiple healthcare providers. Home Care involves at-home testing solutions that offer convenience and early detection outside traditional healthcare settings. Among these, Hospitals and Clinics dominate the market due to their frontline role in patient care, especially during RSV seasons when respiratory infections surge. Their need for rapid, accurate diagnostics to manage outbreaks and provide immediate treatment drives substantial demand for RSV diagnostic products, making them the largest and most influential end-user segment in the market.
RSV Diagnostics Market- Geographical Insights
Geographically, the RSV Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.
North America holds a dominant position in the RSV diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of innovative diagnostic technologies, and high healthcare spending. The region experiences a significant burden of RSV infections, especially among infants and elderly populations, increasing demand for accurate and rapid testing. Additionally, strong government support, well-established reimbursement policies, and presence of leading market players contribute to robust market growth. The growing awareness among healthcare providers and patients about the importance of early RSV diagnosis further fuels the expansion of the market in North America.
Asia Pacific is another dominant region in the RSV diagnostics market, propelled by a large patient population and rising incidence of respiratory infections. Rapid urbanization, improving healthcare facilities, and increasing investments in healthcare infrastructure enhance the adoption of RSV diagnostic solutions. Countries such as China, India, and Japan are key contributors, supported by growing government initiatives to combat infectious diseases. Additionally, increasing awareness and accessibility to diagnostic testing in both urban and rural areas are driving market growth, making Asia Pacific a critical and fast-growing segment in the global RSV diagnostics landscape.
RSV Diagnostics Market- Competitive Landscape:
The RSV diagnostics market is shaped by established diagnostics firms and innovative newcomers focusing on enhanced accuracy and rapid detection. Key players such as Abbott, Roche, Thermo Fisher, and Becton Dickinson dominate the market with a wide range of high-quality diagnostic kits, instruments, and assays. These companies invest heavily in R&D to improve test sensitivity, reduce turnaround time, and comply with stringent regulatory standards. Emerging companies are introducing novel molecular and point-of-care testing solutions, increasing competition. This dynamic fosters continuous innovation, expanding the adoption of RSV diagnostics across hospitals, clinics, and laboratories, thereby improving respiratory infection management globally.
Recent Developments:
In April 2024, Abbott launched a next-generation point-of-care molecular test for RSV and influenza, delivering faster and more accurate respiratory infection diagnosis to support better patient outcomes in diverse clinical settings.
In June 2023, BD completed the sale of its surgical instruments and laparoscopic instrumentation business to STERIS plc, streamlining its portfolio to focus on core diagnostic and medical device segments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RSV DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Biomerieux
- Becton, Dickinson and Company (BD)
- Abbott
- Roche
- Danaher
- Thermo Fisher
- Biocartis
- Luminex
- Hologic
- Fast Track Diagnostics
- Others
GLOBAL RSV DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Kits and Assays
- Instruments
- Other Products
GLOBAL RSV DIAGNOSTICS MARKET, BY METHOD - MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostics
- Rapid Antigen Detection Tests
- Enzyme-Linked Immunosorbent Assays
- Immunofluorescence Assays
- Other Rapid Antigen Detection Tests
- Chromatographic Immunoassays
- Optical Immunoassays
- Other Methods
GLOBAL RSV DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals and Clinics
- Clinical Laboratories
- Home Care
GLOBAL RSV DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. RSV Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. RSV Diagnostics Market Snippet by Product
- 2.1.2. RSV Diagnostics Market Snippet by Method
- 2.1.3. RSV Diagnostics Market Snippet by End User
- 2.1.4. RSV Diagnostics Market Snippet by Country
- 2.1.5. RSV Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. RSV Diagnostics Key Market Trends
- 3.1. RSV Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. RSV Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. RSV Diagnostics Market Opportunities
- 3.4. RSV Diagnostics Market Future Trends
4. RSV Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. RSV Diagnostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. RSV Diagnostics Market Landscape
- 6.1. RSV Diagnostics Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. RSV Diagnostics Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Kits and Assays
- 7.1.3. Instruments
- 7.1.4. Other Products
8. RSV Diagnostics Market - By Method
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
- 8.1.2. Molecular Diagnostics
- 8.1.3. Rapid Antigen Detection Tests
- 8.1.3.1. Enzyme-Linked Immunosorbent Assays
- 8.1.3.2. Immunofluorescence Assays
- 8.1.3.3. Other Rapid Antigen Detection Tests
- 8.1.3.3.1. Chromatographic Immunoassays
- 8.1.3.3.2. Optical Immunoassays
- 8.1.4. Other Methods
9. RSV Diagnostics Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2. Hospitals and Clinics
- 9.1.3. Clinical Laboratories
- 9.1.4. Home Care
10. RSV Diagnostics Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. RSV Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. RSV Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. France
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.8.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. Italy
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.9.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. Spain
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.10.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. United Kingdom
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.11.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Russia
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.12.3. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Netherlands
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.13.3. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Sweden
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.14.3. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. RSV Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. South Korea
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.9.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. Japan
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.10.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. RSV Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. RSV Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- RSV Diagnostics Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Biomerieux
- 11.2.2. Becton, Dickinson and Company (BD)
- 11.2.3. Abbott
- 11.2.4. Roche
- 11.2.5. Danaher
- 11.2.6. Thermo Fisher
- 11.2.7. Biocartis
- 11.2.8. Luminex
- 11.2.9. Hologic
- 11.2.10. Fast Track Diagnostics
- 11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
